New Data Link Food Preservatives to Higher Cancer, T2D Risk - Medscape
Google News • 1/21/2026 – 1/23/2026
Summary
New data links food preservatives to a higher risk of cancer and type 2 diabetes (T2D). A study indicates that preservatives in ultra-processed foods raise prostate cancer risk by 32%. This has brought attention to the clean label movement in food products.
Advertisement
Lindy Score Breakdown (V4.2)
73d
Age
1
Sources
from cluster
1699
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1699/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1699/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 72 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Stat News • 2 days ago
STAT reporter goes up against radiologists to spot deepfake X-rays
Stat News • 1 day ago
Supreme Court conversion therapy decision could ripple through medicine
Stat News • Today
Supreme Court rules against conversion therapy ban
Stat News • 2 days ago
CDC stops testing for rabies, pox viruses
Stat News • 1 day ago
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • 1 day ago
STAT+: Makary marks one year at FDA with focus on achievements in speech to staff
Stat News • 2 days ago
STAT+: Large AI scribe study finds modest time savings, inconsistent use
Stat News • 2 days ago
Opinion: Medical marijuana should not be recommended for PTSD, anxiety, or depression
Stat News • 2 days ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago